China’s SFDA To Air Test Results Of Lethal Human Immunoglobin
This article was originally published in PharmAsia News
Chinese authorities have completed a week-long test of human immunoglobin believed connected with six deaths in the Jiangxi Province. The State FDA recalled all 6,247 bottles of the suspected antibody produced by Jiangxi Boya Pharmaceutical. The test results have not been determined, but an SFDA spokeswoman said they would be released as soon as they are concluded. (Click here for more
You may also be interested in...
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.